Diabetes decisions — 2025

The Board dismissed the Veteran's appeal for service connection for diabetes mellitus type II, bilateral lower extremity diabetic peripheral neuropathy, a kidney transplant, and a liver transplant. The issues of service connection for a bilateral eye disability and hypertension were remanded.

The Board denied service connection for prostate cancer and diabetes mellitus, type II as there was no evidence of in-service exposure to herbicide agents or asbestos, and the conditions did not manifest during service or within one year of discharge.

The Board denied an initial disability rating in excess of 40 percent for the Veteran's service-connected diabetes mellitus type I, as there was no evidence that his condition required hospitalizations or twice monthly visits to a diabetic care provider.

The Board remands the claims for service connection for type II diabetes mellitus, hypertension, flat feet, pseudofolliculitis barbae (PFB), and a kidney condition due to inadequate medical opinions and missing evidence.

The Board remands the Veteran's claims for service connection for chronic lymphocytic leukemia, pleural effusion with smooth pleural thickening, diabetes mellitus, type 2, right-sided tremors, and left-sided tremors due to a pre-decisional duty to assist error.

The Board granted service connection for type II diabetes mellitus based on a direct link to the Veteran's active military service.

The Board remands the Veteran's claims for service connection for a bilateral knee disability and diabetes mellitus, type II to obtain new VA medical examinations.

The Board granted earlier effective dates for service connection of diabetes mellitus type II, hypertension, and hypothyroidism based on the Veteran's exposure to herbicide agents during his service in Thailand.

The Board denied service connection for a psychiatric disability, amphetamine use disorder in sustained remission, diabetes mellitus Type II, hyperhidrosis, migraines, and bilateral carpal tunnel syndrome under 38 U.S.C. Chapter 17.

The Board granted service connection for Parkinson's disease, ischemic heart disease (aortic stenosis), and diabetes mellitus type II based on the Veteran's presumed exposure to herbicide agents during his service in Vietnam.

The Veteran was granted an earlier effective date of August 1, 2023, for the grant of service connection for sarcoidosis with asthma. The initial rating for diabetes mellitus type 2 was denied prior to March 12, 2024, but a 20 percent rating was granted from that date.

The Board remands the claims for service connection for total left hip replacement/avascular necrosis of the left hip, total right hip replacement/avascular necrosis of the right hip, status post lumbar laminectomy, and diabetes mellitus, type II, as new and relevant evidence has been received since the Veteran's RAMP opt-in on June 28, 2018.

The Board denied the veteran's claims for increased ratings and earlier effective dates, finding that the evidence did not support a higher rating or an earlier effective date.

The Board remands the claims for service connection and compensation under 38 U.S.C. § 1151 due to a need for additional evidence, specifically outstanding military personnel records and service treatment records, as well as an adequate medical opinion.

The veteran withdrew the appeal, and all claims were dismissed.

The Board denied increased ratings for hypertension, coronary artery disease and stable angina, and diabetes mellitus type II but granted separate evaluations for diabetic peripheral neuropathy of the upper and lower extremities.

The Board remands the claims for service connection for the Veteran's cause of death and Dependency and Indemnity Compensation under 38 USC 1318 due to a need for a medical opinion regarding the etiology of the Veteran's causes of death, considering toxic exposure at Camp Lejeune.

The appeal for service connection of type 2 diabetes mellitus, as due to herbicide agent exposure, on bases other than the PACT Act was dismissed by the veteran's surviving spouse.

The Board granted service connection for diabetes mellitus type 2, diabetic neuropathy secondary to diabetes and throat cancer, and seborrheic dermatitis secondary to diabetes.

The Board denied the veteran's claims for service connection for diabetes mellitus II, heart disease, hypertension, and a skin/rash disorder as there was no evidence to support that these conditions were related to his military service.